Trastuzumab deruxtecan in breast cancer
Article in Critical Reviews in Oncology/Hematology (April 2024)
The most recent citing publications are shown below. View all 48 publications that cite this research output on Dimensions.
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15).
Article in Therapeutic Advances in Medical Oncology (January 2024)
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
Article in Nature Reviews Clinical Oncology (January 2024)